EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

Treatment patterns and survival in T4b esophageal cancer: a retrospective cohort study

Bin-Bin Yu, Jiang-Qiong Huang, Huan-Wei Liang, Yang Liu, Long Chen, Su Pei, Wei Huang, Xin-Bin Pan

Aging · 2024

DOI: 10.18632/aging.205747 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Aging, 2024. Verfasst von Bin-Bin Yu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, Guangxi, P.R. China. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Neoplasm Staging. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: This study aims to evaluate the efficacy of various treatment approaches in stage T4b esophageal cancer patients. MATERIALS AND METHODS: Data were extracted from the Surveillance, Epidemiology, and End Results databases, covering patients diagnosed with esophageal cancer between 2000 and 2020. Kaplan-Meier analysis was used to assess cancer-specific survival (CSS) and overall survival (OS) across different treatment patterns. RESULTS: The study included 482 patients: 222 (46.1%) received chemoradiotherapy, 58 (12.0%) underwent radiotherapy alone, 37 (7.7%) received chemotherapy alone, 50 (10.4%) underwent surgery, and 115 (23.8%) received no treatment. Median CSS were 12, 4, 6, 18, and 1 month for chemoradiotherapy, radiotherapy alone, chemotherapy alone, surgery, and non-treatment groups. Median OS for these groups were 11, 3, 6, 17, and 1 month, respectively. Multivariable proportional hazard regression analysis revealed that patients who underwent surgery experienced significantly improved CSS (hazard ratio [HR] = 0.42, 95% confidence interval [CI]: 0.24-0.72; P = 0.002) and OS (HR = 0.45, 95% CI: 0.28-0.74; P = 0.002) compared to those receiving chemoradiotherapy after propensity score matching. CONCLUSIONS: Esophagectomy, with or without radiotherapy and/or chemotherapy, results in better survival outcomes than chemoradiotherapy in patients with stage T4b esophageal cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal NeoplasmsNeoplasm StagingHumansMaleFemaleMiddle AgedRetrospective StudiesAgedChemoradiotherapySEER ProgramEsophagectomyKaplan-Meier EstimateTreatment Outcome

Stichwörter der Autor:innen

T4besophageal cancersurvivaltreatment patterns

Autor:innen und Institutionen

  • Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, Guangxi, P.R. China.

Zitieren

APA

Yu, B. B., Huang, J. Q., Liang, H. W., Liu, Y., Chen, L., Pei, S., Huang, W., & Pan, X. B. (2024). Treatment patterns and survival in T4b esophageal cancer: a retrospective cohort study. Aging. https://doi.org/10.18632/aging.205747

Vancouver

Yu BB, Huang JQ, Liang HW, Liu Y, Chen L, Pei S, et al. Treatment patterns and survival in T4b esophageal cancer: a retrospective cohort study. Aging. 2024. doi:10.18632/aging.205747

BibTeX
@article{Yu2024,
  author = {Yu, Bin-Bin and Huang, Jiang-Qiong and Liang, Huan-Wei and Liu, Yang and Chen, Long and Pei, Su and Huang, Wei and Pan, Xin-Bin},
  title = {Treatment patterns and survival in T4b esophageal cancer: a retrospective cohort study},
  journal = {Aging},
  year = {2024},
  doi = {10.18632/aging.205747}
}
Kostenlos starten →